Ji Yao Holding Group Co., Ltd. (300108.SZ)
CNY 1.87
(-1.57%)
CNY 1.87
(-1.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.42 Billion CNY | -4.89% |
| 2022 | 1.49 Billion CNY | -19.64% |
| 2021 | 1.85 Billion CNY | -1.72% |
| 2020 | 1.89 Billion CNY | 17.95% |
| 2019 | 1.6 Billion CNY | 24.86% |
| 2018 | 1.28 Billion CNY | 174.3% |
| 2017 | 468.24 Million CNY | -4.68% |
| 2016 | 491.24 Million CNY | 51.68% |
| 2015 | 323.86 Million CNY | -23.91% |
| 2014 | 425.6 Million CNY | 2209.59% |
| 2013 | 18.42 Million CNY | 232.41% |
| 2012 | -13.91 Million CNY | 74.93% |
| 2011 | -55.52 Million CNY | 68.08% |
| 2010 | -173.93 Million CNY | -2605.99% |
| 2009 | -6.42 Million CNY | 7.25% |
| 2008 | -6.93 Million CNY | 53.66% |
| 2007 | -14.95 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 1.32 Billion CNY | -22.51% |
| 2024 Q2 | 1.7 Billion CNY | 20.24% |
| 2024 Q1 | 1.41 Billion CNY | -0.07% |
| 2023 Q1 | 1.46 Billion CNY | -1.82% |
| 2023 Q3 | 1.43 Billion CNY | -0.18% |
| 2023 Q4 | 1.42 Billion CNY | -1.15% |
| 2023 Q2 | 1.44 Billion CNY | -1.81% |
| 2023 FY | 1.42 Billion CNY | -4.89% |
| 2022 Q4 | 1.49 Billion CNY | -19.81% |
| 2022 Q2 | 1.86 Billion CNY | -0.16% |
| 2022 Q1 | 1.86 Billion CNY | 0.53% |
| 2022 FY | 1.49 Billion CNY | -19.64% |
| 2022 Q3 | 1.86 Billion CNY | -0.17% |
| 2021 Q1 | 1.87 Billion CNY | -0.63% |
| 2021 Q4 | 1.85 Billion CNY | -1.38% |
| 2021 FY | 1.85 Billion CNY | -1.72% |
| 2021 Q3 | 1.88 Billion CNY | 1.3% |
| 2021 Q2 | 1.86 Billion CNY | -0.99% |
| 2020 Q3 | 1.8 Billion CNY | -0.08% |
| 2020 Q1 | 1.63 Billion CNY | 1.93% |
| 2020 FY | 1.89 Billion CNY | 17.95% |
| 2020 Q2 | 1.81 Billion CNY | 10.79% |
| 2020 Q4 | 1.89 Billion CNY | 4.54% |
| 2019 Q3 | 1.58 Billion CNY | 0.18% |
| 2019 FY | 1.6 Billion CNY | 24.86% |
| 2019 Q4 | 1.6 Billion CNY | 0.9% |
| 2019 Q2 | 1.58 Billion CNY | 0.23% |
| 2019 Q1 | 1.58 Billion CNY | 23.24% |
| 2018 Q3 | 1 Billion CNY | 33.02% |
| 2018 Q4 | 1.28 Billion CNY | 27.91% |
| 2018 FY | 1.28 Billion CNY | 174.3% |
| 2018 Q1 | 575.3 Million CNY | 22.86% |
| 2018 Q2 | 754.89 Million CNY | 31.22% |
| 2017 Q2 | 579.68 Million CNY | 0.12% |
| 2017 Q1 | 578.99 Million CNY | 17.86% |
| 2017 FY | 468.24 Million CNY | -4.68% |
| 2017 Q4 | 468.24 Million CNY | -25.22% |
| 2017 Q3 | 626.16 Million CNY | 8.02% |
| 2016 Q1 | 404.35 Million CNY | 24.85% |
| 2016 Q4 | 491.24 Million CNY | -13.07% |
| 2016 Q3 | 565.13 Million CNY | 16.43% |
| 2016 Q2 | 485.39 Million CNY | 20.04% |
| 2016 FY | 491.24 Million CNY | 51.68% |
| 2015 Q1 | 452.73 Million CNY | 6.37% |
| 2015 FY | 323.86 Million CNY | -23.91% |
| 2015 Q4 | 323.86 Million CNY | -37.85% |
| 2015 Q3 | 521.09 Million CNY | 10.39% |
| 2015 Q2 | 472.05 Million CNY | 4.27% |
| 2014 FY | 425.6 Million CNY | 2209.59% |
| 2014 Q4 | 425.6 Million CNY | 19.96% |
| 2014 Q3 | 354.8 Million CNY | 1150.15% |
| 2014 Q2 | 28.38 Million CNY | -39.45% |
| 2014 Q1 | 46.87 Million CNY | 154.35% |
| 2013 Q4 | 18.42 Million CNY | -57.04% |
| 2013 FY | 18.42 Million CNY | 232.41% |
| 2013 Q1 | 11.86 Million CNY | 185.26% |
| 2013 Q2 | 15.47 Million CNY | 30.41% |
| 2013 Q3 | 42.89 Million CNY | 177.23% |
| 2012 Q2 | -24.02 Million CNY | 39.91% |
| 2012 Q3 | -16.25 Million CNY | 32.35% |
| 2012 Q1 | -39.97 Million CNY | 28.0% |
| 2012 FY | -13.91 Million CNY | 74.93% |
| 2012 Q4 | -13.91 Million CNY | 14.36% |
| 2011 Q2 | -119.41 Million CNY | 23.82% |
| 2011 Q1 | -156.75 Million CNY | 9.88% |
| 2011 Q3 | -89.54 Million CNY | 25.01% |
| 2011 Q4 | -55.52 Million CNY | 38.0% |
| 2011 FY | -55.52 Million CNY | 68.08% |
| 2010 Q2 | 9.48 Million CNY | 0.0% |
| 2010 Q4 | -173.93 Million CNY | 18.87% |
| 2010 Q3 | -214.4 Million CNY | -2361.39% |
| 2010 FY | -173.93 Million CNY | -2605.99% |
| 2009 Q4 | -6.42 Million CNY | 0.0% |
| 2009 FY | -6.42 Million CNY | 7.25% |
| 2008 FY | -6.93 Million CNY | 53.66% |
| 2007 FY | -14.95 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 1.13 Billion CNY | -25.382% |
| Yixintang Pharmaceutical Group Co., Ltd. | 1.21 Billion CNY | -17.381% |
| ZJAMP Group Co., Ltd. | -2.65 Billion CNY | 153.566% |
| Luyan Pharma Co.,Ltd. | 4.23 Billion CNY | 66.442% |